Trial Details

TERMINATED
Basic Information
Clinical ID c1521
Identifier NCT02092389
Trial Title Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Moderate to Severe Ulcerative Colitis
Interventions -
Participant Information
Sponsor AbbVie
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-07-14
Primary Completion Date 2025-10-15
Completion Date 2025-03-16